Comprehensive Commercialization Solutions For Emerging Diagnostics

We simplify the path to market for innovative diagnostic technologies across the disease spectrum

Our Mission

Ethos Research + Development

We partner with early-stage clinical diagnostic companies to simplify and accelerate their path to market. Our comprehensive approach to commercialization ensures that your diagnostic test will impact patient lives sooner.

Whether you are looking for a partner to direct the development and validation of an early-stage diagnostic concept or simply a CLIA laboratory to house and introduce your test to the US market our team is ready to connect.

WHO WE ARE

Targeting New Heights

Our founders and leadership teams have spent the past 15 years operating high complexity CLIA laboratories, developing and introducing novel biomarker tests, and conducting NIH funded research. Our 30,000 square feet state of the art CLIA laboratory services physician and hospital clients nationwide and our clinical education/sales teams routinely introduce novel test offerings to our client base. Let’s chat about how our existing infrastructure and vast experience in the clinical lab space could accelerate the launch of your diagnostic technology.